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Charged Beads Enhance Cutaneous Wound
Healing in Rhesus Non-Human Primates
Elisa Burgess, M.D., Jeffrey Hollinger, D.D.S., Ph.D., Steven Bennett, Ph.D., John Schmitt, B.S.,
Dave Buck, M.S., Robert Shannon, M.S., Seong-Pill Joh, M.D., Ph.D., Jaghu Choi, M.D., Ph.D.,
Thomas Mustoe, M.D., Xuanhan Lin, B.S., Walter Skalla, B.S., Dave Connors, B.S.,
Chris Christoforou, M.S., and Elliott Gruskin, Ph.D.
Portland, Ore., North H aven, Conn., nnd Chicago, Ill:

Enhanced cutaneous wound healing by positively
charged cross-linked diethylaminoethyl dextran beads
(CLOD) was studied in a standardized incisional wound
model in 20 adult and 20 geriatric 111acaca mulatta (rhesus)
partitioned equally over five time periods. Physiologic saline served as a control. Soft-tissue linear incisions were
prepared between and l cm inferior to the scapulae.
There were four incisions per rhesus; each incision was 1.5
cm long with 1 cm of undisturbed tissue between incisions,
and both the experimental CLDD and physiologic saline
treatments were administered to each rhesus. The incision
treatments were either CLDD and soft-tissue closure with
4-0 BioSyn sutures or sterile physiologic saline and closure
with 4-0 BioSyn smures. The hypothesis was CLDD would
enhance cutaneous wound repair. Verification of the h ypothesis consisted of clinical examinations and histologic
and tensiometric evaluations on biopsy specimens at 10
and 15 days, whereas 5-day and 2- and 4-month groups
were assessed clinically and biopsy specimens were assessed histolog"ically.
The clinical course of healing for all groups was unremarkable. At 10 days, incisions in adult rhesus treated with
CLDD had a 30-percent greater tensile strength compared
with the physiologic saline-treated incisions (p = 0.01),
whereas for geriatric rhesus, the CLDD treatment proved
to be 15 percent greater in tensile strength compared with
the physiologic saline cohort (p = 0.11). By day 15, incisions in adult rhesus were 26 percent stronger than the
saline treatment group (/J = 0.07), and the difference was
36 percent (p = 0.02) for the geriatric rhesus. From 5
through 15 days, histologic observations revealed a gradual decrease in quantity and integrity of CLOD, with no
remnants ofCLDD at either 2 or 4 months. Macrophages
and multinucleated giant cells wer.e localized in the dermis and were associated with the CLDD. These cells decreased commensurately with the decrease of CLDD
beads.
The data suggest that CLDD can enhance significantly
the tensile properties of healing cutaneous wounds in
both adult and geriatric rhesus. Moreover, if the wound
h ealing is enhanced in geriatric p atie nts, this finding may

be clinically germane to conditions where wound healing
is compromised, such as in diabetics and patients on steroids.

In contemporary health care, economic and
effective therapies to enhance cutaneous
wound healing have taken center stage. Although the efficacy of recombinant human
(rh) growth factors is acknowledged to benefit
the cutaneous wound-healing cascade, persuasive data are wanting, and pecuniary considerations are constraints. Therefore, cost-efficient,
clinically effective alternatives have been
sought. An example of a compelling alternative
is electrical stimulation. However, electrical
stimulation applied to cutaneous wounds has a
complex and contradictory legacy. The notion
that an electrical stimulation could enhance
cutaneous wound repair is derived from cutaneous injury data, where the epidermis of the
skin becomes electronegative ,with respect to
the dermis. A "current of injury" to damaged
cutaneous tissue purportedly provokes a current, 22 µA/ cm2, that terminates when the
tissue heals. The electrical current may result
~rom deformation of the crystalline structure
of collagen in the extracellular matrix, thus
producing a wound-stimulating piezoelectric
effect. 1 Alterations in the extracellular matrix
may in turn regulate cells and gene expression
through the intracellular cytoskeleton, 2•3 leading to secretion of vulnerary factors for tissue
repair.

Furthermore, as a result of cutaneous
wotu1ding, the "current of i1tjury" tnay be stimulated by fluxes in fluid flow at the injury locus,
producing electrokinetic-generated streaming
poteutial. 1 Purportedly, streaming potential
can modulate blood flow. For example, negative electrical stimulation can increase blood
flow. 4 Angiogenesis (i.e., the growth of branching capillaries) and blood flow are pivotal for
cutaneous wound repair5 and are controlled
through interactive dynamics among the extracellular matrix, cells, and the signaling factors
expressed by cells. Macrophages are influential
cells th.at direct events during the woundhealing cascade''- 7 through expression of several signaling molecules, including plateletderived growth factor, epidermal growth
factor, transforming growth factor, fibroblast
growth factor, and insulin-like growth factor. 8•9
At the completion of wound healing, the "current of injury" ceases, and resident cell populations become consistent with the pre-injured
phenotype. It is speculative whether a toggling
interaction among cells, extracellular matrix,
signaling molecules, and the "current of injury" sustains the wound healing cascade and
with renewal of the epidermis-dermis, if a "current of injury" off-switch down-regulates cell
activity.
Relevant to electrical currents, charges, and
polarity and cutaneous healing is the population of cells affiliated with the wound-healing
continuum and their predictable appearance
during wound repair. 10 The macrophage is a
marquis cell affiliated with tissue repair, 6 ·7 and
a positive charge seems to solicit vectorial macrophage migration. 11 Furthermore, the "current of injury" and electronegativity between
the dermis and epidermis could establish a
"charged field gradient" influencing macrophage navigation toward the more electropositive dermis. Localization of macrophages
within the dermis may provide a critical mass of
cells to secrete signaling molecules necessary
to restore the dermis and the epidermis. Fibroblasts also respond to electrical charge stimulation, and evidence suggests an enhancement
of fibroblast DNA and collagen synthesis, 1 further underscoring the beneficial utility of therapeutic electrical current and charges.
Unfortunately, anecdotal, equivocal clinical
results, and contradictory experimental observations have marred the acceptance of electrical stimulation for therapeutic wound repair.
Moreover, it has been difficult to ensure a lo-

calized effect from a designated polarity.
Therefore, a therapeutic with a known charge
density, with polarity that could be controlled
and applied locally, could provide clinical efficacy. Consistent with this notion was the application of "ionically charged" beads that could
be targeted to a wound site. We previously
hypothesized ionic charges could be exploited
to fulfill the physiologic roles speculated for
"electrical fields" to stimulate and to enhance
wound repair. In a reported study, we previously proved this hypothesis in a rat model and
determined positively charged cross-linked diethylaminoethyl dextran beads (CLDD) enhanced cutaneous wound healing. 12 Consequently, the next logical step was to validate
the effectiveness of positively charged CLDD in
Macaca mulatta (rhesus), a species highly relevant to man. Therefore, the general hypothesis
for the current study was that positively
charged CLDD would enhance cutaneous
wound healing in the rhesus. Moreover, in
light of the growing geriatric population in the
United States and the clinical observations of a
lag in wound healing in the elderly, a geriatric
cohort of rhesus was included. The hypothesis
was the CLDD would benefit the geriatric rhesus by enhancing cutaneous repair. The long
range goal for the therapeutic CLDD is application as a clinical adjunctive treatment for
patients who are likely candidates to have a
delayed cutaneous healing response, such as
the geriatric, diabetic, or individual on steroids.
MATERIALS AND METHODS

Preparation of CLDD

Positively charged cross-linked diethylaminoethyl dextran beads (DEAE Sephadex A-25,
Pharmacia) were prepared by treating the
DEAE with sodium periodate according to a
method previously reported. 13 · 14 In brief, 150 g
of vacuum-dried diethylaminoethyl beads were
hydrated with 24. 72 g of sodium periodate in
2.5 liters of water. After 90 minutes, beads were
washed with 5 M sodium chloride and acidified
with 1 M hydrochloric acid followed with a
water wash to remove excess acid, yielding a
size range of beads 40 to 120 µm. Beads were
suspended in a polyethylene glycol - mixture
(97% polyethylene glycol 300:3% polyethylene
glycol 200,000) at a ratio of 0.1 g of CLDD
beads to 10 ml of polyethylene glycol. Known
amounts of CLDD/polyethylene glycol were

sterilized with 21.5 to 40 kiloGray of gamma
irradiation, aseptically inserled into sterile
squeeze tubes, and maintained in an aseptic
manner until surgical implantation.
Animal GroufJs, Smge1y, and Incision Model

Healthy female NI. mulatta rhesus from the
Oregon Regional Primate Center were identified, and a cohort of 20 was selected as the
adult group, ranging in age from 4 to 11 years
old. An additional group of 20 rhesus were
geriatric; they were 18 to 20 years old.
Preoperative handling and general anesthesia were managed in the usual fashion. The
surgical site was prepped and draped in a sterile manner.
Operatively, each rhesus received four linear
incisions between and 1.5 cm inferior to the
scapulae. The incisions were 1.5 cm in length
and 1 cm apart through the epidermis, dermis,
and panniculus adiposus without disturbing
underlying muscular fascia. Incision margins
were elevated, and the tissue plane between
the panniculus adiposus and muscular fascia
was advanced with blunt dissection for an additional 5 mm. No electrocautery was used.
Either 0.25 cc of topical CLDD or an equivalent volume of physiologic saline was administered to alternating incisions. CLDD was
back.loaded into a 1.0-cc sy1inge with no needle
and applied both directly in the wound and
underneath the adjacent edges of the wound.
The sterile, 0.9% physiologic saline (McGaw
Inc., Irvine, Calif.) was administered in a similar fashion. Incisions were closed with simple
interrupted sutures (4-0 BioSyn, US Surgical,
North Haven, Conn.). Neither antibiotic salve
nor dressing was applied.
Following therapy, rhesus were returned to
their individual cages for postsurgical recovery
and were given free access to food and water.
Their movement was not restricted. Postoperative analgesia was not required. Over the
course of the study, incisional sites were assessed by routine clinical examination for deliiscence, e rythema, and drainage.
B iopsy

At the designated times after incisional
wounding (5, 10, or 15 days and 2 and 4
months), rhesus were r e turned to the operating room, anesthetized, prepped, and draped
in a sterile fashion. An elliptical portion of
epidermis, dermis, and subcutaneous adipose
tissue encompassing the original incisions was

dissected carefully, and the resulting deficit
was closed using subcuticular and vertica l mattress sutures.
Using a template with surgical blades, the
biopsy specimen was par titioned into individual specimens for histology and tensiome try
for the 10- and 15-day groups, whereas only
histology specimens were recovered for the
5-day and 2- and 4-month groups. Standardsized strips of tissue that included l!) mm on
each side of the incisional wound were
trimmed carefully (total length of 30 mm) and
were wrapped immediately in foil, placed on
dry ice, and stored at - 80°C. Specimens designated for histology were fixed immediately in
70% ethanol.
Tensiomel1)' for 10 and 15 Days

There were four incisional wounds per rhesus that were treated with either physiologic
saline or CLDD. Consequently, tensiometric
measurements were accomplished on a designated specimen of tissue from each incisional
wound providing eight test specimens for each
temporal period (10 and 15 days).
In preparation for tensiometric testing, specime ns were thawed at a constant rate and standard manner and were allowed to stabilize to
room temperature before tensile testing.
Tensile strength of the wounds was measured with a Tensiometry 10 (Mon santo, St.
Louis, Mo .) at a crosshead speed of 10 mm/
min. A recording was made for each tissue
sample subjected to tensile loading and tensiornetry data for physiologic saline and CLDD
al each time period (i.e., 10 and 15 days) and
age group (i.e., adult and geriatric). Data were
reported as a mean plus one standard deviation with significance established at jJ = 0.05.
H istology

Following fixation from 70 to 100% ethanol,
specimens were processed for glycol methacrylate and sectioned to 4.5-µ,m thickness, and
alternatir.g sections were stained with either
Goldner-Masson trichrome or hematoxylin
and eosin. Histologic sections were examined
witl1 bright fie ld light microscopy (Zeiss Axiophot Microscope, Zeiss Inst-ruments Co., Inc. ,
New York, N.Y.).
Statistics

Statistical analyses were done to determine
treatment and age··dependent effects of physiologic saline and CLDD on the mean tensile

strength of the cutaneous wounds. Data were
analyzed by a n analysis of variance and Fisher's
protected least significant difference test to detennine differences between treatments and
times within each age and interactions of age,
treatments, and Limes. Significance was establish ed at p = 0.05, and data were p resen ted as
mean tensile strength (in newtons) plus one
standard deviation.
·
RESULTS

Tensile Strength

Only 10- and 15-day time periods were assessed. At 5 days, cutaneous tissues are too
im mature to respond to tensiomeu-ic assessing;
therefore, it is not possible to measure and
detect differences between treatments. At 2
and 4 months, cutan eous tissue maturity mitigates against tensiometric discrimination between treatme nts.
The 10-day tensiometry results indicated that
the CLDD-treated wounds for the adull rhesus
Tenslometry
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had a 30-percenL increase in breaking strength
compared with the physiologic saline-treated
wounds (Fig. 1). The CLDD-Lreated wounds
for the geriatric rhesus h ad a 14-percent increase in breaking strength compared the
physio logic salinne-treated wounds.
At 15 days, for the adult rhesus, incisional
wounds treated with the CLDD yielded a 25.8percent increase in breaking strength for incisional wounds compared with the physiologic
saline-treated wounds (Fig. 1). Geriatric rhesus
administered the CLDD h ad a 36.3-percent increase in breaking strength compared with the
physiologic saline-treated wounds.
Irrespective of treatments and time, the cutaneous wounds appeared similar from days 5
through 15. By 2 months, histologic evidence
of an incision was extremely difficult to confirrn, even in the geriatric group. By 4 months,
there was no histologic evidence ofa cutaneous
incision.
Observations for the 5- through 15-day specimens included an epidermal thickening at the
incision with subjacent hyperplasia of connective tissue stroma and numerous robust fibroblasts. In the dermis of the rhesus treated with
CLDD, there seemed to be a more organized,
vectoriaUy oriented collection of collagenous
fibers, wi th less birefringence than for the
physiologic saline treatm ents (Fig. 2, below).
CLDD beads were localized Lo the dermis, and
bead degeneration increased from day 5
through 15, with no evidence of the CLDD
beads al either 2 or 4 mon ths (Figs. 2 through
4) .

Contiguous to the beads were either macrophages or multinucleated giant cells (Figs. 3,
above, and 4) . T h e numbers of these cells decreased concomitantly with bead degeneration
from 5 though 15 days. Lymph9cytes and occasional neutrophils and monocytes also were
observed.
Drscuss10N

Day 10

Day 15

Fie;. 1. Tensiometric data (10- and 15-day) are presented
for adult and aged rhesus. Each b<ir 1·epresents a mean of 10
1-hesus, and e1Tor bars represent l standard deviation. Statistical significance was established at p = 0.05. CLDD, positively
changed cross-linked diethylaminoethyl dexu·an beads; PS,
physiologic saline.

Healing of cutaneous wounds may not be
problematic for healthy individuals. However,
with an increasing geriatric population in the
United States, a commensurate burden in
health care challe nges will be generated. It is
hi ghly likely that cutaneous wound healing in
the elderly would benefit from an effective,
cost-efficient therapeutic. Consistent with this
co ncept was the development. of positively
charged CLDD beads to enhance cutaneous
wound healing. Moreover, the design of this

FIG. 2. (Above) The histologic appearance of an incisional wound at 10 days posttreatment
with CLDD. Arrows,vith 1, 2, and 3 deliinit epidermis, dennis, and subdermis, respectively. Black
arrows ('vithout nu1nbers) indicate the incisional wound zone still visible in the dermis; however,
the epidennis is intact. The CLDDs are observed in the transitional region at the base of the
dennis (T) (2.5X tnagnilication, Goldner trichrome stain). (Below, left) A slightly higher magnification than panel above. Black arrows indicate the incisional wound zone visible in the dermis.
CLDDs are observed at the base of the dermis (T), and CLDD re1nnants arc identified by the
star. The nuved anvws indicate sebaceous glands typically found in the epidermis and are
associated with hair follicles (5X inagnification, Goldner trichrome stain). (Below, right) The
incisional wound counterpart of previous panel (below, left) shown at the same magnification.
Black arrows indicate the incisional \Vound zone visible in the dermis. (5X magnification, Goldner
trichro1ne stain).

FIG. 3. (Above) Appearance of the incisional wound at 10 days posttreatrnent wi.th CLDD.
Anvws ·with I, 2, and 3 delimit epidennis, dermis, and subdennis, respectively. Black arrows
(without nu1nbers) indicate the incisional wound zone in the dermis. The epidennis is intact,
and keratinized component is apparent (dark-staining band). The CLDDs are observed in the
transitional region at the base of the dermis (T) admixed with round cell infla1n1natory infiltrate
(2.5X magnification, Goldner trichrome stain). (Below, lejl) A slightly higher n1agnification than
panel above. CLDDs are observed at the base of the dern1is (T), and the round cell infla1nmatory
infiltrate is identified by the sta1: The curved anvw indicates the sebaceous gland-hair follicle
con1plex (5X magnification, Goldner trichrome stain). (Below, right) The incisional wound
counterpart of the previous panel is shown at the sa1ne tnagnification. Black arrows indicate the
incisional wound track visible in the dermis. Collagen bundle orientation is random, and distinct
gaps are present (5X n1agnification, Goldner trichrome stain).

FIG. 4. (Panel A) Appearance of the incisional wound at
10 days posttreatinent with CLI)D. Black arrows indicate the
incisional wound zone in the dermis (2.5X magnification,
Goldner trichrome stain). (Panel B) A partially degraded
CLDD enveloped by histiocytic-appearing cells (lOX magnification, Goldner trichrome stain). (Panel C) A partially degraded CLOD enveloped by and containing sn1all round lymphocytic-appearing cells (lOX inagnification, Goldner
trichrome stain).

study focused on optimizing clinical relevance
to the human population; thus, the rhesus was
selected as a candidate wound model. The rational approach we followed was to build on
the significant bank of preclinical data1·2.l3·28·29·34 that clearly indicated the benefit of
positively charged CLDD. Consequently, we
compared the positively charged CLDD with a
"common surgical practice": irrigation of a
wound site.
Results strongly suggest CLDD therapy enhanced tensile strength for 10- and 15-day temporal groups in adult and geriatric rhesus. Although there was more variability (i.e., a
greater standard deviation) in the L'>-day cohort than the 10-day cohort, statistical analyses
of the tensiometric data clearly indicated a

significant (36 percent) improvement for the
geriatric rhesus treated with CLDD versus physiologic saline. Biologic variation and the cellular and stromal variables of cutaneous wound
healing may have more significant impact on
cutaneous healing outcome at 15 days than at
10 days.
The greatest increase in tensile strength was
achieved at 15 days in the geriatric rhesus
treated with CLDD, where the CLDD-treated
incisional wounds were 36 percent stronger
than the wounds administered physiologic saline. This is a highly relevant clinical finding
fortifying the notion that a cost-effective, topically applied "biomaterial" could improve cutaneous incisional wound repair. Although
growth factors have been administered to cutaneous wounds to enhance healing, variability
in responses coupled with their expense underscores the appeal of the CLDD therapeutic.
Lynch 15 has applied combinations of platelet-derived growth factor and insulin-like
growth factor delivered in a methyl cellulose
carrier to partial-thickness cutaneous wounds
and observed enhanced epithelialization. Several reports have noted the benefit' of epithelial growth factor in promoting cutaneous healing,16-19 whereas other studies have demonstrated ineffectiveness with epidermal growth
factor. 20 ·21 Mustoe and others have shown combinations of platelet-derived growth factor-BB,
transforming growth factor-beta, and fibroblast
growth factor improve wound-breaking
strength in a rat incision model. 22- 25 In addition, recent data imply that systemic administration of growth hormone (but not insulinlike growth hormone) to malnourished,
diabetic, steroid-treated, hypophysectomized,
and normal animals improves the incisional
wound tensile strength (reviewed by Robertson
et al. 26 ). Despite the provocative potential of
growth factors, they have not caught on as
clinical therapeutics. Difficulties with delivery
of the factors, variability in concentrations of
growth factor among different studies, ambiguities in assessment criteria, and expense have
deterred widespread clinical acceptance. An
appealing alternative is the biomaterial known
as CLDD. In the characterized rhesus model,
CLDD proved to be an effective, safe, and inexpensive therapeutic.
According to tensiometric data, the CLDD
treatment significantly enhanced the breaking
strength of incisional wounds in adult rhesus at
10 days. By 15 days, incisional wounds in the

adult rhesus treated with physiologic saline had
a comparable tensile strength to the CLDD
treatments. Data from the 10-day geriatric cohort, although not statistically significant, suggested an increase in wound tensile strength
with CLDD. However, at 15 days, the geriatric
rhesus treated with CLDD had a statistically
significant 36-percent increase in wound tensjle strength above physiologic saline treatment. We hypothesize this is the result of delayed wound healing in the aged rhesus. That
is, a temporal delay in appearance of woundhealing elements required additional time to
enable CLDD efficacy. Therefore, with additional time, the effectiveness of the CLDD was
realized. Consequently, by day 15, the beneficial affects of CLDD were apparent with the
geriatric population, whereas the positive influences of CLDD were detected by 10 days for
the adult population.
Histologically, for 10- and 15-day wounds,
the epidermal and dermal layers of the CLDD
and physiologic saline cohorts seemed to be
indistinguishable. There were macrophages
and multinucleated giant cells associated with
CLDD remnants, with occasional lymphocytes,
neutrophils, and monocytes in the dermal
st:roma. The histologic impression was consistent with a low grade, localized reaction
around the CLDDs. Grossly, the incisional
wounds treated with CLDD seemed clinically
normal.
Mechanistically, cutaneous wound-healing
enhancement by CLDDs is unclear. It is recognfaed that macrophages are highly important
for cutaneous wound repair, 27 and it has been
shown during dermal wound healing that electrical current plays a defining role in the directional migration of these cells and other phenotypes. 4 Moreover, it seems that macrophages
preferentially migrate toward a positive
charge, ll,28 •29 and positively charged materials
invoke a favorable wound-healing response in
rat incisional wounds. 12 It is well known that
expression of macrophage-derived growth factors stimulate fibroblasts and optimize the
quantity and organization of collagenous stroma. 6 •8 •30 - 32 Although the tensiometric data
clearly portrayed the superiority of the CLDD
to physiologic saline, histologic observations
did not present a striking cellular and morphologic picture at any of the temporal periods.
There was a decrease in charged beads from
days 5 through 15, and they were absent by 2
months. Similarly, by histologic observation,

the number of macrophages and giant cells
diminished with the decrease in CLDD beads.
An additional observation was that during
injury repair, macrophages were found in the
dermis. Moreover, topically applied CLDD particles localized to the dermis. As a consequence
of the colocalization, macrophages may recognize CLDD as "foreign" and initiate a cascade
of activities to remove the beads. When the
macrophage response is insufficient to accomplish this deed, development of a multinucleated phenotype (i.e., giant cells) ensues to accomplish the task. Furthermore, attachment of
macrophages to CLDD beads could alter the
shape of the cell 2•33 •34 (i.e., mechano-transduction) and promote expression of vulnerary
growth factors to promote cutaneous healing.
However, it is not clear why positive charges
preferentially attract macrophages and why
and how the macrophages are activated by positive charges. No attempt was made in this
study to elucidate the mechanisms and signaling factors responsible for the enhancement of
cutaneot1s wound repair in respor1se to the
CLDD. Future studies will address the mechanistic components of this highly significant
phenomenon.
In summary, at 10 days, incisions in adult
rhesus treated with CLDD had a 30-percent
increase in tensile strength compared with saline treatment (p = 0.01), whereas for geriatric
rhesus, the CLDD treatment provided a 15percen t increase in tensile strength com pared
with the physiologic saline (p = 0.11). By day
15, adult rhesus had a 26-percent increase in
tensile strength compared with saline treatment (p = 0.07), and the difference was 36
percent (p = 0.02) for the geriatric rhesus.
From 5 through 15 days, a gradual decrease in
quantity and integrity of CLDD was observed
histologically. No remnants of CLDD were detected at either 2 or 4 months. Therefore, data
suggest that CLDD can enhance significantly
the tensile properties of healing cutaneous
wounds in both the adult and geriatric rhesus.
Moreover, if the wound healing is enhanced in
geriatric patients, this finding may be clinically
germane to conditions where incisional cutaneous wound healing is compromised, such as
in diabetics and patients on steroids.
E. Gruskin, Ph.D.
U.S. Surgical Corporation
Life Sciences Division
195 McDermott Road
North Haven, Conn. 06473
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